INVA vs RXRX

Comparison between Innoviva Inc (INVA, Company) and Recursion Pharmaceuticals Inc - Class A (RXRX, Company).

Both INVA and RXRX are from the Healthcare sector.

5-Year PerformanceINVA has outperformed RXRX, delivering a return of +9.7% compared to -38.8%

INVA vs RXRX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	INVA(COMPANY)	RXRX(COMPANY)
Market Cap	$1.58B	$1.58B
Max Drawdown	84.32%	93.13%
Sharpe Ratio	0.34	-0.80
5Y Beta	0.15	2.62
Industry	Biotechnology	Biotechnology
P/E Ratio	3.09	-2.58
Forward P/E	10.86	N/A
5Y EPS CAGR	16.74%	-10.03%
Debt to Equity	19.24%	0.00%
Free Cash Flow Yield	11.50%	-20.61%

Market Cap

Winner

INVA

$1.58B

RXRX

$1.58B

Max Drawdown

Winner

INVA

84.32%

RXRX

93.13%

Sharpe Ratio

Winner

INVA

0.34

RXRX

-0.80

5Y Beta

Winner

INVA

0.15

RXRX

2.62

Industry

INVA

Biotechnology

RXRX

Biotechnology

P/E Ratio

INVA

3.09

Winner

RXRX

-2.58

Forward P/E

INVA

10.86

RXRX

N/A

5Y EPS CAGR

Winner

INVA

16.74%

RXRX

-10.03%

Debt to Equity

INVA

19.24%

Winner

RXRX

0.00%

Free Cash Flow Yield

Winner

INVA

11.50%

RXRX

-20.61%

INVA vs RXRX - Historical Returns

Returns include dividend reinvestment.

Period	INVA	RXRX
1 month	-9.98%	-4.75%
3 months	-9.71%	-14.00%
6 months	+8.38%	-36.36%
1 year	+9.96%	-53.19%
5 years(CAGR)	+9.68%	-38.80%
10 years(CAGR)	+6.32%	N/A
Max(CAGR)	+2.07%	-35.89%

INVA

-9.98%

Winner

RXRX

-4.75%

Winner

INVA

-9.71%

RXRX

-14.00%

Winner

INVA

+8.38%

RXRX

-36.36%

Winner

INVA

+9.96%

RXRX

-53.19%

5Y(CAGR)

Winner

INVA

+9.68%

RXRX

-38.80%

10Y(CAGR)

INVA

+6.32%

RXRX

N/A

Max(CAGR)

Winner

INVA

+2.07%

RXRX

-35.89%

INVA vs RXRX - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	INVA	RXRX
2026	+6.69%	-28.33%
2025	+14.89%	-43.27%
2024	+5.99%	-31.51%
2023	+20.87%	+30.60%
2022	-24.07%	-57.24%
2021	+38.22%	-45.27%
2020	-11.06%	N/A
2019	-18.15%	N/A
2018	+20.93%	N/A
2017	+27.38%	N/A
2016	+3.68%	N/A
2015	-20.54%	N/A
2014	-50.22%	N/A
2013	+58.87%	N/A
2012	+8.49%	N/A
2011	-13.91%	N/A
2010	+87.93%	N/A
2009	-7.50%	N/A
2008	-36.30%	N/A
2007	-37.82%	N/A
2006	+39.21%	N/A
2005	+26.87%	N/A
2004	-1.16%	N/A

INVA vs RXRX Drawdown Comparison

The maximum drawdown for INVA was -84.32%, occurring on Nov 21, 2008. Recovery took 1504 trading sessions.

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The current INVA drawdown is -33.61%. The current RXRX drawdown is -92.72%.

Rank	INVA	RXRX
#1	-84.32% May 22, 2007 - May 13, 2013	-93.13% Jul 13, 2021 - Mar 30, 2026
#2	-78.77% Jul 11, 2013 - Sep 29, 2015	-38.10% Apr 29, 2021 - Jun 17, 2021
#3	-26.22% Apr 5, 2006 - Oct 19, 2006	-10.54% Apr 16, 2021 - Apr 21, 2021
#4	-21.77% Feb 8, 2007 - May 22, 2007	-10.45% Jun 21, 2021 - Jul 6, 2021
#5	-20.78% May 14, 2013 - Jul 11, 2013	-8.29% Apr 21, 2021 - Apr 29, 2021
#6	-16.58% Oct 21, 2004 - Mar 8, 2005	N/A
#7	-13.06% Oct 25, 2005 - Jan 17, 2006	N/A
#8	-12.25% Mar 8, 2005 - Jul 25, 2005	N/A
#9	-10.48% Feb 9, 2006 - Apr 5, 2006	N/A
#10	-8.88% Oct 27, 2006 - Jan 12, 2007	N/A
#11	-5.70% Oct 7, 2004 - Oct 21, 2004	N/A
#12	-5.63% Aug 1, 2005 - Sep 15, 2005	N/A
#13	-5.52% Jan 16, 2007 - Feb 7, 2007	N/A
#14	-4.40% Sep 20, 2005 - Oct 14, 2005	N/A
#15	-2.38% Feb 2, 2006 - Feb 8, 2006	N/A

Correlation

Correlation between INVA and RXRX is -0.42 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.42

-101